|
Goserelin Acetate Clinical Trials
4 actively recruiting trials across 4 locations
Also known as: ZDX, Zoladex
Pipeline
Phase 2: 2Phase 3: 2
Top Sponsors
- SWOG Cancer Research Network1
- Manish Patel1
- ECOG-ACRIN Cancer Research Group1
- City of Hope Medical Center1
Indications
- Cancer4
- Stage IVB Prostate Cancer AJCC v83
- Stage IVA Prostate Cancer AJCC v82
- Stage IV Prostate Cancer AJCC v82
- Metastatic Prostatic Adenocarcinoma1
Anchorage, Alaska1 trial
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Anchorage Associates in Radiation Medicine
Phase 3
Gilbert, Arizona1 trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Banner MD Anderson Cancer Center
Phase 3
Duarte, California1 trial
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
City of Hope Medical Center
Phase 2
Chicago, Illinois1 trial
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma
Northwestern University Feinberg School of Medicine
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.